Inventor
BHATT PADMANABH P
US44 patents
⚠️ This page may combine multiple inventors who share the name “BHATT PADMANABH P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUPERNUS PHARMACEUTICALS INC
30 patentsUS7611728B2Nov 3, 2009
Osmotic delivery of therapeutic compounds by solubility enhancement
SUPERNUS PHARMACEUTICALS INC75 citations93
US9119792B2Sep 1, 2015
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC5 citations84
US10265319B2Apr 23, 2019
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC4 citations83
US9662338B2May 30, 2017
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC5 citations83
US9358204B2Jun 7, 2016
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC7 citations83
US9119791B2Sep 1, 2015
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC2 citations74
US8017149B2Sep 13, 2011
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC2 citations74
US7910131B2Mar 22, 2011
Method of treating seizures using modified release formulations of oxcarbazepine
SUPERNUS PHARMACEUTICALS INC4 citations74
US7722898B2May 25, 2010
Modified-release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC5 citations74
US11896599B2Feb 13, 2024
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC0 citations73
US11166960B2Nov 9, 2021
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC0 citations73
US10220042B2Mar 5, 2019
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC1 citations73
US11077114B2Aug 3, 2021
Stabilized formulations of CNS compounds
SUPERNUS PHARMACEUTICALS INC1 citations72
US10149853B2Dec 11, 2018
Stabilized formulations of CNS compounds
SUPERNUS PHARMACEUTICALS INC2 citations72
US9603853B2Mar 28, 2017
Formulations of viloxazine
SUPERNUS PHARMACEUTICALS INC3 citations72
US9855278B2Jan 2, 2018
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC1 citations63
US9393203B2Jul 19, 2016
Osmotic drug delivery system
SUPERNUS PHARMACEUTICALS INC1 citations63
US9370525B2Jun 21, 2016
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC1 citations63
US9351975B2May 31, 2016
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC1 citations63
US8821930B2Sep 2, 2014
Modified release preparations containing oxcarbazepine and derivatives thereof
SUPERNUS PHARMACEUTICALS INC1 citations63
US10005743B2Jun 26, 2018
Methods for producing viloxazine salts and novel polymorphs thereof
SUPERNUS PHARMACEUTICALS INC1 citations58
US10314790B2Jun 11, 2019
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US10154965B2Dec 18, 2018
Osmotic drug delivery system
SUPERNUS PHARMACEUTICALS INC0 citations52
US9622983B2Apr 18, 2017
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US9555004B2Jan 31, 2017
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US9549940B2Jan 24, 2017
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US8992989B2Mar 31, 2015
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US8877248B1Nov 4, 2014
Sustained-release formulations of topiramate
SUPERNUS PHARMACEUTICALS INC0 citations52
US10160733B2Dec 25, 2018
Methods for producing viloxazine salts and novel polymorphs thereof
SUPERNUS PHARMACEUTICALS INC0 citations48
US9434703B2Sep 6, 2016
Viloxazine compositions
SUPERNUS PHARMACEUTICALS INC0 citations48
LIANG LIKAN
7 patentsUS8598191B2Dec 3, 2013
Controlled release compositions of gamma-hydroxybutyrate
LIANG LIKAN76 citations96
US8193211B2Jun 5, 2012
Controlled release compositions of gamma-hydroxybutyrate
LIANG LIKAN87 citations96
US8298580B2Oct 30, 2012
Sustained-release formulations of topiramate
LIANG LIKAN12 citations92
US8663683B2Mar 4, 2014
Sustained-release formulations of topiramate
LIANG LIKAN4 citations83
US9403783B2Aug 2, 2016
Methods for producing viloxazine salts and novel polymorphs thereof
LIANG LIKAN6 citations79
US8889191B2Nov 18, 2014
Sustained-release formulations of topiramate
LIANG LIKAN1 citations62
US8298576B2Oct 30, 2012
Sustained-release formulations of topiramate
LIANG LIKAN1 citations62